Prostemics Co. Ltd (203690) - Total Liabilities

Latest as of March 2026: ₩14.84 Billion KRW ≈ $10.05 Million USD

Based on the latest financial reports, Prostemics Co. Ltd (203690) has total liabilities worth ₩14.84 Billion KRW (≈ $10.05 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 203690 net asset momentum to track the company's year-over-year net asset growth rate.

Prostemics Co. Ltd - Total Liabilities Trend (2015–2025)

This chart illustrates how Prostemics Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does Prostemics Co. Ltd generate to measure how efficiently the company converts operating cash flow to free cash.

Prostemics Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Prostemics Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Filament Health Corp NEO:FH	Canada	CA$1.94 Million
Astron Paper & Board Mill Limited NSE:ASTRON	India	Rs1.26 Billion
BT Wealth Industries Public Company Limited BK:BTW	Thailand	฿443.67 Million
MJ Gleeson plc LSE:GLE	UK	GBX111.71 Million
ETRUSCUS RESOURCES CORP. F:ERR	Germany	€189.69K
Nexera Energy Inc V:NGY	Canada	CA$32.63 Million
Rainbow Rare Earths Limited LSE:RBW	UK	GBX12.88 Million

Liability Composition Analysis (2015–2025)

This chart breaks down Prostemics Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Prostemics Co. Ltd market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.03	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.60	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.37	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Prostemics Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Prostemics Co. Ltd (2015–2025)

The table below shows the annual total liabilities of Prostemics Co. Ltd from 2015 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩16.49 Billion ≈ $11.18 Million	-53.02%
2024-12-31	₩35.10 Billion ≈ $23.79 Million	-24.92%
2023-12-31	₩46.76 Billion ≈ $31.69 Million	+12.25%
2022-12-31	₩41.65 Billion ≈ $28.23 Million	+6.17%
2021-12-31	₩39.23 Billion ≈ $26.59 Million	+1.37%
2020-12-31	₩38.70 Billion ≈ $26.23 Million	+1010.42%
2019-12-31	₩3.49 Billion ≈ $2.36 Million	+144.64%
2018-12-31	₩1.42 Billion ≈ $965.48K	-0.11%
2017-12-31	₩1.43 Billion ≈ $966.56K	-35.29%
2016-12-31	₩2.20 Billion ≈ $1.49 Million	-43.58%
2015-12-31	₩3.91 Billion ≈ $2.65 Million	--

About Prostemics Co. Ltd

KQ:203690 Korea Biotechnology

Market Cap

$1.88 Million

₩2.78 Billion KRW

Market Cap Rank

#30084 Global

#2100 in Korea

Share Price

₩139.00

Change (1 day)

+0.00%

52-Week Range

₩139.00 - ₩139.00

All Time High

₩77250.00